CollPlant Biotechnologies Ltd. (CLGN) Stock Forecast
CLGN analyst forecast
as of October 17, 2026- Analyst consensus
- —
- Price target
- $11.12 average of analyst targets
- Upside to target
- +206.8% from the latest close
- Next earnings
- —
- 52-week range
- $2.73 – $24.90
CLGN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CLGN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$0.59 | −$0.59 | −$0.59 | −$0.94 | +37.2% | 1 |
| Next fiscal year (2027) | −$0.18 | −$0.18 | −$0.18 | −$0.59 | +69.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CLGN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (2026) | $6.1M | $6.1M | $6.1M | −17.3% | 1 |
| Next fiscal year (2027) | $7.6M | $7.6M | $7.6M | +25.0% | 1 |
CLGN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CLGN revenue: reported and forecast
CLGN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$0.04 | −$0.41 | −$0.41 | −$0.59 | −$0.59 | +1,211.1% | 0 up · 1 down |
| Next fiscal year (2027) | −$0.02 | −$0.03 | −$0.03 | −$0.01 | −$0.18 | +800.0% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CLGN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CLGN beat in 1 of 12.
What analysts expect from CLGN
The average price target is $11.12, 206.8% above the latest close of $3.62. Analysts expect earnings of −$0.59 per share for 2026, +37.2% from a year earlier. For 2027 the average estimate is −$0.18 per share on revenue of $7.6 million. CollPlant Biotechnologies beat the EPS estimate in 1 of the last 12 quarters.
Related: CLGN income statement, CLGN key metrics, CLGN chart. See the CLGN stock overview for the latest quote and news.
CLGN forecast FAQ
What is CollPlant Biotechnologies's price target?
The average analyst price target for CollPlant Biotechnologies is $11.12, 206.8% above the latest close of $3.62.
What is CollPlant Biotechnologies's EPS forecast?
Analysts forecast −$0.59 per share for 2026 (range −$0.59 to −$0.59); for 2027 the estimate is −$0.18.
What is CollPlant Biotechnologies's revenue forecast?
The average revenue estimate for 2026 is $6.1 million, growth of −17.3%; for 2027 it is $7.6 million.
Does CollPlant Biotechnologies usually beat earnings estimates?
CollPlant Biotechnologies reported EPS at or above the analyst estimate in 1 of the last 12 quarters.